⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGM

VCYT

Veracyte, Inc.

Healthcare · Diagnostics & Research

43.86USD

+1.4100 (+3.32%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 43.86
P/E30.8
Dvd Ind Yld—
P/B2.54
P/S6.3
Curr EV/T12M EBITDA24.3
Mkt Cap (USD)3.5B
Curr EV (USD)3.1B
2)

Per Share Data

EPS T12M1.41
DPS—
Bk Val Per Sh17.28
Rev/Sh6.85
Cash/Sh6.04
Curr Shares Out80.4M
FCF/Sh2.02
3)

Cash Flow Analysis

P/CF19.8
Curr P/FCF21.2
CF/NI1.6
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales31.7%
Eff Interest Rate39.9%
4)

Growth Potential

Dil EPS 1Y Gr164.5%
Cap 1Y Gr11.4%
BPS 1Y Gr8.0%
R&D To Sales16.6%
Retention Rate100.0%
Rev 1Y Gr16.0%
FCF 1Y Gr98.5%
Assets 1Y Gr8.2%
5)

Profitability

EBITDA0.1B
EBIT0.1B
Operating Margin18.8%
Pretax Margin20.6%
Net Margin20.4%
ROA8.1%
ROE8.8%
ROC7.5%
Asset Turnover0.40
6)

Structure

Current Ratio9.16
Quick Ratio8.60
Debt/Assets0.0%
Debt/Com Eq0.0%
Net Debt/EBITDA-2.37
Tot Debt/Capital0.0%
Gross Margin71.7%
EBIT/Int Exp470.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.